CASP3 and triple-negative breast carcinoma: In in vitro experiments, by promoting the expression of cyt c, caspase-9 and caspase-3 and blocking the expression of matrix metalloproteinase 9 (MMP-9), it has a significant antimetastatic effect on triple-negative breast cancer (TNBC) [71].